common.study.topics.clinical

Assessing Ovarian Function During Prolonged Implant Use

common.study.values.description

Assessing Ovarian Function During Prolonged Implant Use

The study will evaluate how the ovaries may be functioning while using the the ImplanonAR/NexplanonAR during the three years beyond the FDA approved duration. Ovarian function will be assessed with weekly serum progesterone levels. Participants will undergo weekly venipuncture for a total of four draws. Participants will be followed for 30 days.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Device - Etonogestrel Implant

Ovarian function will be assessed with weekly serum progesterone levels. Participants will undergo weekly venipuncture for a total of four draws over a 30 day period. Participants will also complete a bleeding diary to assess daily bleeding patterns for the 30 day study period.

participant.views.study.view.additional

participant.views.study.view.scientific-title

Assessing Ovarian Function During Prolonged Implant Use

common.study.values.clinical-trial-id

NCT03058978

participant.views.study.view.id

PdRJKd